Previous 10 | Next 10 |
In addition to inflationary pressure, growing concerns about the potential aftermath of the Russia-Ukraine war and the Western and EU economic sanctions imposed on Russia have been fueling immense market volatility. So, we think investors seeking to 'bottom-fish' in the beaten-down market cou...
MOUNTAIN VIEW, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company will release financial results for the fourth qua...
MOUNTAIN VIEW, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX) today provided preliminary unaudited operational and financial results for the fourth quarter and full year ended January 1, 2022. Fourth Quarter 2021 Total revenue expected to be $15....
MOUNTAIN VIEW, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company plans to participate in the upcoming 2021 Stifel Virtu...
IRIDEX Corporation (IRIX) Q3 2021 Earnings Conference Call November 11, 2021 17:00 ET Corporate Participants Hunter Cabi - Investor Relations Dave Bruce - Chief Executive officer Fuad Ahmad - Interim Chief Financial Officer Conference Call Participants Jon Block - Stifel Presentation Operator...
MOUNTAIN VIEW, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX) today reported financial results for the third quarter ended October 2, 2021. Third Quarter Highlights Revenue of $13.3 million, an increase of 51% from the prior year period, and 24% ...
An international expert consensus panel will discuss best practices in dosing and patient selection using MicroPulse TLT on November 6, 2021 Panel members scheduled for discussions at the Iridex booth during AAO meeting on November 13-15th MOUNTAIN VIEW, Calif., Nov. 06, 2...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips There’s a reason why so many investors have micro-cap stocks in their portfolio. When a company has a market capitalization of between $50 million and $300 million, there is inherently more risk involved than with la...
MOUNTAIN VIEW, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company will release financial results for the third quar...
MOUNTAIN VIEW, Calif., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company plans to participate in the upcoming Lytham Partners ...
News, Short Squeeze, Breakout and More Instantly...
MOUNTAIN VIEW, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial results...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
MOUNTAIN VIEW, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced the Company...